oral tirzepatide clinical trials after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial FDA Approves Tirzepatide, A Potential

In a trial of semaglutide injection (Wegovy) in patients with T2DM and BMI of 27 kg/m2 or more, diabetic retinopathy was reported by 4% of semaglutide-treated patients vs

HMO enrollment is significantly higher in the West (25%), and significantly lower in the Midwest (6%) [Figure 5.3]

While they help improve blood sugar control and support weight loss, its important to understand how these medications, along with diabetes itself, can increase the risk of heat-related illness in Central Texas summer heat

Another cross-sectional study prospectively recruited patients adhering to preprocedural fasting protocols before elective anesthesia revealed that, after controlling for confounding variables, the use of GLP-1 RAs was associated with a 30.5% increase in the prevalence of increased residual gastric contents

Weight loss takes time For many, meaningful fat loss begins after 812 weeks , especially once doses reach 10mg or 15mg weekly